NBNicholas Lee Berlin

Nicholas Lee Berlin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nicholas Lee Berlin has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Balancing Oversight and Innovation

    by Alex J. Dong, Nicholas L. Berlin, Thomas C. Tsai

  • Open Access

    Catastrophic health expenditures, insurance churn, and non-employment among women with breast cancer

    by Nicholas L Berlin, Benjamin B Albright, Haley A Moss, Anaeze C Offodile

    Background: Breast cancer treatment and survivorship entails a complex and expensive continuum of subspecialty care. Our objectives were to assess catastrophic health expenditures, insurance churn, and non-employment among women younger than 65 years who reported a diagnosis of breast cancer. We also evaluated changes in these outcomes related to implementation of the Affordable Care Act. Methods: The data source for this study was the Medical Expenditure Panel Survey (2005-2019), which is a national annual cross-sectional survey of families, providers, and insurers in the United States. To assess the impact of breast cancer, comparisons were made with a matched cohort of women without cancer. We estimated predicted marginal probabilities to quantify the effects of covariates in models for catastrophic health expenditures, insurance churn, and non-employment. Results: We identified 1490 respondents younger than 65 years who received care related to breast cancer during the study period, representing a weight-adjusted annual mean of 1 062 129 patients. Approximately 31.8% of women with breast cancer reported health expenditures in excess of 10% of their annual income. In models, the proportion of women with breast cancer who experienced catastrophic health expenditures and non-employment was inversely related to increasing income. During Affordable Care Act implementation, mean number of months of uninsurance decreased and expenditures increased among breast cancer patients. Conclusions: Our study underscores the impact of breast cancer on financial security and opportunities for patients and their families. A multilevel understanding of these issues is needed to design effective and equitable strategies to improve quality of life and survivorship.


  • Association of bundled payments with spending, utilization, and quality for surgical conditions: A scoping review

    by Ahmad M. Hider, Amalia E. Gomez-Rexrode, Josh Agius, Mark P. MacEachern, Andrew M. Ibrahim, Scott E. Regenbogen, Nicholas L. Berlin


  • Prescriptions for Mitigating Climate Change–Related Externalities in Cancer Care: A Surgeon's Perspective

    by Victor Agbafe, Nicholas L. Berlin, Charles E. Butler, Ernest Hawk, Anaeze C. Offodile Ii

    @victoragbafe @NickBerlin_MD @anaeze_offodile @mdandersonnews lay out a broad framework for embedding climate change sensitivity in surgical oncology practice. Levers for change are: updating the o...


  • Perceived financial decline related to breast reconstruction following mastectomy in a diverse population‐based cohort

    by Nicholas L. Berlin, Paul Abrahamse, Adeyiza O. Momoh, Steven J. Katz, Reshma Jagsi, Ann S. Hamilton, Kevin C. Ward, Sarah T. Hawley

    Background: Despite mandated insurance coverage for breast reconstruction following mastectomy, health care costs are increasingly passed on to women through cost‐sharing arrangements and high‐deductible health plans. In this population‐based study, the authors assessed perceived financial and employment declines related to breast reconstruction following mastectomy.Methods: Women with early‐stage breast cancer (stages 0‐II) diagnosed between July 2013 and May 2015 who underwent mastectomy were identified through the Surveillance, Epidemiology, and End Results registries of Georgia and Los Angeles and were surveyed. Primary outcome measures included patients' appraisal of their financial and employment status after cancer treatment. Multivariable models evaluated the association between breast reconstruction and primary outcomes.Results: Among 883 patients with breast cancer who underwent mastectomy, 44.2% did not undergo breast reconstruction, and 55.8% underwent reconstruction. Overall, 21.9% of the cohort reported being worse off financially since their diagnosis (25.8% with reconstruction vs 16.6% without reconstruction; P = .002). Women who underwent reconstruction reported higher out‐of‐pocket medical expenses (32.1% vs 15.6% with expenses greater than $5000; P < .001). Reconstruction was independently associated with a perceived decline in financial status (odds ratio, 1.92; 95% confidence interval, 1.15‐3.22; P = .013). Among women who were employed at the time of their diagnosis, there was no association between reconstruction and a perceived decline in employment status (P = .927).Conclusions: In this diverse cohort of women who underwent mastectomy, those who elected to undergo reconstruction experienced higher out‐of‐pocket medical expenses and self‐reported financial decline. Patients, providers, and policymakers should be aware of the potential financial implications related to reconstruction despite mandatory insurance coverage.


  • Open Access

    The Costs of Breast Reconstruction and Implications for Episode-Based Bundled Payment Models

    by Nicholas L. M.D. Berlin, Kevin C. M.D. Chung, Evan M.D. Matros, Jung-Sheng M.Sc. Chen, Adeyiza O. Momoh

    Background: Implementation of payment reform for breast reconstruction following mastectomy demands a comprehensive understanding of costs related to the complex process of reconstruction. Bundled payments for services to women with breast cancer may profoundly impact reimbursement and access to breast reconstruction. The authors’ objectives were to determine the contribution of cancer therapies, comorbidities, revisions, and complications to costs following immediate reconstruction and the optimal duration of episodes to incentivize cost containment for bundled payment models. Methods: The cohort was composed of women who underwent immediate breast reconstruction between 2009 and 2016 from the MarketScan Commercial Claims and Encounters database. Continuous enrollment for 3 months before and 24 months after reconstruction was required. Total costs were calculated within predefined episodes (30 days, 90 days, 1 year, and 2 years). Multivariable models assessed predictors of costs. Results: Among 15,377 women in the analytic cohort, 11,592 (75 percent) underwent tissue expander, 1279 (8 percent) underwent direct-to-implant, and 2506 (16 percent) underwent autologous reconstruction. Adjuvant therapies increased costs at 1 year [tissue expander, $39,978 (p < 0.001); direct-to-implant, $34,365 (p < 0.001); and autologous, $29,226 (p < 0.001)]. At 1 year, most patients had undergone tissue expander exchange (76 percent) and revisions (81 percent), and a majority of complications had occurred (87 percent). Comorbidities, revisions, and complications increased costs for all episode scenarios. Conclusions: Episode-based bundling should consider separate bundles for medical and surgical care with adjustment for procedure type, cancer therapies, and comorbidities to limit the adverse impact on access to reconstruction. The authors’ findings suggest that a 1-year time horizon may optimally capture reconstruction events and complications.


  • Open Access

    Demand for Surgical Procedures Following COVID-19

    by Nicholas L. Berlin, Justin B. Dimick, Eve A. Kerr, Ted A. Skolarus, Lesly A. Dossett


  • Hospital Variations in Clinical Complications and Patient-reported Outcomes at 2 Years After Immediate Breast Reconstruction

    by Nicholas L. Berlin, Vickram J. Tandon, Ji Qi, Hyungjin M. ScD Kim, Jennifer B. Hamill, Adeyiza O. Momoh, Andrea L. Md Pusic, Edwin G. Wilkins

    Objective: Our objectives were to investigate case-mix adjusted hospital variations in 2-year clinical and patient-reported outcomes following immediate breast reconstruction. Background: Over the past few decades, variations in medical practice have been viewed as opportunities to promote best practices and high-value care. Methods: The Mastectomy Reconstruction Outcomes Consortium Study is an National Cancer Institute-funded longitudinal, prospective cohort study assessing clinical and patient-reported outcomes of immediate breast reconstruction after mastectomy at 11 leading medical centers. Case-mix adjusted comparisons were performed using generalized linear mixed-effects models to assess variation across the centers in any complication, major complications, satisfaction with outcome, and satisfaction with breast. Results: Among 2252 women in the analytic cohort, 1605 (71.3%) underwent implant-based and 647 (28.7%) underwent autologous breast reconstruction. There were significant differences in the sociodemographic and clinical characteristics, and distribution of procedure types at the different Mastectomy Reconstruction Outcomes Consortium Study centers. After case-mix adjustments, hospital variations in the rates of any and major postoperative complications were observed. Medical center odds ratios for major complication ranged from 0.58 to 2.13, compared with the average major complication rate across centers. There were also meaningful differences in satisfaction with outcome (from the lowest to highest of −2.79–2.62) and in satisfaction with breast (−2.82–2.07) compared with the average values. Conclusions: Two-year postoperative complications varied widely between hospitals following post-mastectomy breast reconstruction. These variations represent an important opportunity to improve care through dissemination of best practices and highlight the limitations of extrapolating single-institution level data and the ongoing challenges of studying hospital-based outcomes for this patient population.


  • Feasibility and Efficacy of Decision Aids to Improve Decision Making for Postmastectomy Breast Reconstruction: A Systematic Review and Meta-analysis

    by Nicholas L. Berlin, Vickram J. Tandon, Sarah T. Hawley, Jennifer B. Hamill, Mark P. MacEachern, Clara N. Lee, Edwin G. Wilkins

    Background. The decision-making process for women considering breast reconstruction following mastectomy is complex. Research suggests that fewer than half of women undergoing mastectomy have adequate knowledge and make treatment decisions that are concordant with their underlying values. This systematic review assesses the feasibility and efficacy of preoperative decision aids (DAs) to improve the patient decision-making process for breast reconstruction. Methods. A systematic review was performed using PubMed, Ovid MEDLINE, EMBASE, CINAHL, and Cochrane Databases published prior to January 4, 2018. Studies that assessed the impact of a DA on patient decision making for breast reconstruction were identified. The effect of preoperative DAs on decisional conflict in randomized controlled trials (RCTs) was measured with inverse variance-weighted mean differences (mean difference [MD] ± 95% confidence interval [CI]). Results. Among 1299 unique articles identified, 1197 were excluded after reviewing titles and abstracts against selection criteria. Among the 17 studies included in this review, 11 assessed the efficacy of DAs for breast reconstruction and 6 additional studies described the development and usability of these DAs. Studies suggest that DAs reduce patient-reported decisional conflict (MD, –4.55 [95% CI, –8.65 to –0.45], P = 0.03 in the fixed-effects model and MD, –4.70 [95% CI, –10.75 to 1.34], P = 0.13 in the random-effects model). Preoperative DAs also improved patient satisfaction with information and perceived involvement in the decision-making process. Conclusions. The existing literature suggests that DAs reduce decisional conflict, improve self-reported satisfaction with information, and improve perceived involvement in the decision-making process for women considering breast reconstruction.